Today we remember Dr. Damira Bayzakova, a CML specialist and cancer advocate from Kyrgyzstan who passed away on November 16th 2020, due to complications with COVID-19. Dr. Bayzakova was an implementing partner for The Max Foundation since 2006, and was monumental in bringing life-saving treatment and cancer diagnostics into Kyrgyzstan.
Dr. Bayzakova (right) with Laboratory specialist, Dr. Govrilenko, standing next to their newly procured diagnostics machine.
Dr. Bayzakova’s efforts to expand access in Kyrgyzstan
During our 2017 transition to Max Access Solutions, Dr. Bayzakova was a key physician in expanding access to cancer drugs for people in her region. Her partnership increased the number of available cancer treatments available to patients, many who are now on second- and third-line treatment.
“Dr. Bayzakova dedicated her life to her patients and through her efforts greatly improved the treatment of CML in her country.”
– Pat Garcia-Gonzalez, CEO, The Max Foundation
Today, Kyrgyzstan patients have access to treatment options for their cancer, giving hundreds the opportunity to continue living with dignity and hope. This achievement is due to Dr. Bayzakova’s immense dedication and hard work
Dr. Bayzakova was also a champion of diagnostic testing and monitoring for her patients as well. We collaborated with Dr. Bayzakova to purchase a GeneXpert machine for diagnosing rare cancers – the first for her hospital. Since then, Dr. Bayzakova worked with Max to conduct over 1,200 PCR tests for pediatric and adult CML patients.
Patients above all
Dr. Bayzakova understood the importance of patient organizations and was very supportive of the local efforts of the patient group leaders. She was a true champion of patients, who always aimed to improve the treatment of CML in Kyrgyzstan. Dr. Bayzakova went so far as to advocate and fundraise for partner hematologists from the neighboring country of Tajikistan. Two specialists from Tajikistan learned under Dr. Bayzakova in order to build a similar in-house diagnostic and monitoring facilities.
Dr. Bayzakova, center in gray jacket, surrounded by cancer patients she supported.
The Max Foundation and all collaborators of Max express deep condolences to the family, relatives and friends of Damira Omurzakovna Bayzakova and share the bitterness of irreplaceable loss. In honor of the life and legacy of Dr. Bayzakova, the International CML Foundation posthumously awarded the 2021 iCMLf Prize to her.
Join us in celebrating Dr. Bayzakova’s life. Make a donation in her honor to continue supporting cancer patients in remote and underserved regions.
Sukhrob has worked with Dr.Bayzakova since 2011 to 2020 as a friend, colleague and coordinator of the Max programs in Kyrgyzstan. Sukhrob devotes this post in memory and tribute to Dr. Bayzakova's life.
Related Articles
Colors of Hope in The Lancet Oncology
At The Max Foundation, increasing global access to treatment for people around the world living with cancer is a core element of our mission. But access to treatment is only one piece in helping all people facing cancer live with dignity and hope. Fostering care and support for patients processing the hardships of cancer is essential.
Announcing the Excellence in Patient Advocacy Award Winner
At The Max Foundation we are all about patients; deeply, profoundly, committed to patients and by extension their families and communities. To continue to foster this commitment, once a year we honor a team member who has exemplified our values and beliefs with the Excellence in Patient Advocacy Award. We are proud to announce the….
Max CEO’s Ongoing Commitment to Treatment Access Solutions Recognized by iCMLf ERSAP Prize
We’re often reminded of why we put an effort in supporting people facing cancer – whether it comes through a patient story or through an organization’s investment in our work. This week, we humbly received another reminder: on Friday, May 22, the International Chronic Myeloid Leukemia (CML) Foundation awarded our CEO Pat Garcia-Gonzalez with the inaugural ERSAP (Emerging Region Support and Partnership) Prize. The iCMLf Directors and Scientific Advisors selected Pat because of her continued commitment, and The Max Foundation’s aim, to help people face cancer with dignity and hope.
The Max Foundation uses cookies to improve your experience on our site. Please read our Privacy Policy for more information.